At Spinogenix, stories of courage and perseverance drive our mission in developing the novel synaptic regenerative treatments to bring new hope to people living with ALS and other neurodegenerative diseases.
In a recent conversation with our founder and CEO, Dr. Stella Sarraf, Hall of Fame quarterback, philanthropist, and Spinogenix board member Steve Young reflected on how his friend and teammate Dwight Clark’s battle with ALS continues to fuel this mission.
Dwight’s legacy—defined by strength, perseverance, and hope—reminds us why advancing restorative treatments matters so deeply. As Steve shares, Spinogenix is working to pave the way for a new era of therapies that honor that legacy and bring new possibilities to people affected by ALS and their families.
Watch the full conversation below.